Non-Invasive Electrochemical Biosensors for Fibromyalgia: A Path Toward Objective Physiological Monitoring and...

Area of Science:

• Biomedical Engineering
• Clinical Chemistry
• Neuroscience

Background:

• Fibromyalgia (FM) is a complex chronic condition with widespread pain and cognitive issues, lacking definitive diagnostics.
• Current management is difficult due to subjective symptoms and limited objective biomarkers, primarily studied in serum/plasma.
• Salivary biomarkers offer non-invasive potential but face challenges in validation, standardization, and matrix effects.

Purpose of the Study:

• To investigate the potential of salivary biomarkers for fibromyalgia (FM) diagnosis and monitoring.
• To explore the application of advanced electrochemical biosensors for sensitive detection of FM biomarkers in saliva.
• To enable objective, real-time tracking of FM pathophysiology and personalized treatment.

Main Methods:

• Review of existing literature on candidate salivary biomarkers for FM.
• Discussion of challenges and opportunities in salivary biomarker analysis.
• Exploration of electrochemical biosensor technology for multiplexed salivary biomarker detection.

Main Results:

• Salivary biomarkers like alpha-amylase and cortisol show promise but require further validation.
• Electrochemical biosensors offer high sensitivity for low-concentration analytes in saliva.
• Multiplexed biosensor platforms could facilitate longitudinal FM monitoring.

Conclusions:

• Salivary biomarkers, detected via advanced electrochemical biosensors, hold significant potential for objective FM assessment.
• This approach could overcome limitations of current diagnostic methods and subjective reporting.
• Non-invasive, real-time monitoring may revolutionize FM patient management and therapeutic strategies.